Genmab
kr 2,257.00Change from previous close: −2.42%Absolute change: −kr 56.00
At a glance
- Revenue growth
- +19.19%
- 2025 vs 2024
- Net income growth
- −15.00%
- 2025 vs 2024
- Net margin
- 25.9%
- 2024: 36.3%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 12,873 | 6,414 | 5,232 | 4,327 | 3,767 |
| Current assets | 2,885 | 3,900 | 4,912 | 4,054 | 3,478 |
| Cash and equivalents | 1,715 | 1,380 | 2,204 | 1,421 | 1,370 |
| Short-term investments | 0.0 | 1,574 | 1,967 | 1,786 | 1,588 |
| Receivables | 1,152 | 937 | 733 | 847 | 520 |
| Inventory | 18.0 | 9.0 | 8.0 | 0.0 | — |
| Net property, plant and equipment | 280 | 265 | 244 | 190 | 149 |
| Goodwill | 355 | 355 | — | — | — |
| Other intangible assets | 9,123 | 1,728 | 15.0 | 21.0 | 38.9 |
| Long-term investments | 37.0 | 32.0 | 20.0 | 19.1 | 56.7 |
| Current liabilities | 1,427 | 744 | 368 | 262 | 240 |
| Accounts payable | — | — | — | — | 53.5 |
| Long-term debt | 5,001 | — | — | — | — |
| Total debt | 5,426 | 144 | — | 85.9 | — |
| Total liabilities | 7,026 | 1,277 | 545 | 408 | 372 |
| Total equity (incl. minority) | 5,847 | 5,137 | 4,687 | 3,920 | 3,395 |
| Retained earnings | 4,098 | 3,392 | 2,737 | 2,128 | 1,533 |